A detailed history of Verition Fund Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 15,846 shares of VCEL stock, worth $550,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,846
Previous 12,075 31.23%
Holding current value
$550,648
Previous $538,000 25.28%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$37.92 - $45.7 $142,996 - $172,334
3,771 Added 31.23%
15,846 $674,000
Q1 2025

May 15, 2025

BUY
$44.5 - $61.8 $537,337 - $746,235
12,075 New
12,075 $538,000
Q3 2023

Nov 14, 2023

BUY
$31.69 - $39.25 $222,653 - $275,770
7,026 New
7,026 $235,000
Q2 2018

Aug 15, 2018

SELL
$9.6 - $14.6 $144,979 - $220,489
-15,102 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$5.7 - $12.3 $86,081 - $185,754
15,102 New
15,102 $150,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.64B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.